← All trials
NCT05488340
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 13, 2022
- Primary completion
- Jun 30, 2025
- Completion date
- Dec 31, 2025
- First posted
- Aug 4, 2022
- Last posted
- Aug 23, 2022
- Enrollment
- 580
- Arms / groups
- 5 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Locus BiosciencesLead sponsor
- ParexelCollaborator
- Locus BiosciencesStudy director
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.